Drugs Used In Treatment Of Covid
Anakinra, like other IL-1 blocking drugs, is used to treat COVID-19 because the rise in IL-1 levels precedes the increase in IL-6 levels in mice models of cytokine release syndrome, so according to these studies treatment with anakinra resulted in a decrease of both cytokines [112–114]. Molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid) are oral antiviral agents effective at preventing hospitalization and death in patients with mild to moderate COVID-19 who are at high risk* for progression to severe COVID-19. EMCDDA report on trends & developments. T he rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted by this year’s annual report from the EU drugs agency (EMCDDA). The report delivers the latest overview of the drug situation in Europe, exploring long-term trends and emerging threats.